Skip to main content
Clinical Trials/NCT02989376
NCT02989376
Completed
Not Applicable

Emergent Carotid Ultrasound in Hyperacute Cerebral Vessel Occlusion for Selecting Patients to be Treated With Endovascular Clot Retrieval Treatment

Ryo Itabashi1 site in 1 country40 target enrollmentStarted: October 2016Last updated:
ConditionsStroke, Acute

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Ryo Itabashi
Enrollment
40
Locations
1
Primary Endpoint
modified Rankin Scale

Overview

Brief Summary

The aim of this study is to address the usefulness of carotid duplex ultrasound as vascular imaging for selecting acute stroke patients for endovascular thrombectomy.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Endovascular treatment can be initiated within 6 hours of symptom onset.
  • ASPECTS of \>=6 is diagnosed by two or more stroke physicians.
  • The end diastolic velocity in the common carotid arteries or internal carotid artery is evaluated by carotid duplex ultrasound
  • NIHSS score of \>=
  • Age\>=18 years.
  • Written informed consent is obtained.

Exclusion Criteria

  • Pre-stroke modified Rankin Scale (mRS) score \>=
  • Difficulties to evaluate ASPECTS on initial CT.
  • Difficulties to groin puncture.
  • History of severe allergic reaction to contrast medium.
  • End stage renal disease.

Outcomes

Primary Outcomes

modified Rankin Scale

Time Frame: at 90 days after onset

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Ryo Itabashi
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Ryo Itabashi

Department chair of Stroke Neurology

Kohnan Hospital

Study Sites (1)

Loading locations...

Similar Trials